Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

PharmAla Incorporates Australian Entity for Clinical Research

Summary by Muskoka Region
TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo™ MDMA), is pleased to…

3 Articles

ParrySound.comParrySound.com
+2 Reposted by 2 other sources
Lean Left

PharmAla Incorporates Australian Entity for Clinical Research

TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo™ MDMA), is pleased to…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Muskoka Region broke the news in Muskoka Lakes, Canada on Wednesday, September 3, 2025.
Sources are mostly out of (0)

Similar News Topics

Toronto, New South Wales icon

Toronto, New South Wales

News
For You
SearchBlindspotLocal